About Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While a diagnosis can feel overwhelming, understanding your lymphoma is an important first step. This section covers the biology behind DLBCL, what causes it, its subtypes, and what your genetics may mean for your diagnosis and treatment.

Download DLBCL Fact Sheet
Speak to a Lymphoma Care Nurse
Patient & Carer Education
Support Groups

B-cell lymphocytes in Diffuse Large B-cell 
Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While a diagnosis can feel overwhelming, understanding your lymphoma is an important first step. This section covers the biology behind DLBCL, what causes it, its subtypes, and what your genetics may mean for your diagnosis and treatment.

B-Cell lymphocytes:

  • Are a type of white blood cell
  • Fight infection and diseases to keep you healthy. 
  • Remember infections you had in the past, so if you get the same infection again, your body’s immune system can fight it more effectively and quickly. 
  • Are made in your bone marrow (the spongy part in the middle of your bones), but usually live in your spleen and your lymph nodes.  Some live in your thymus and blood too.
  • Can travel through your lymphatic system, to any part of your body to fight infection or disease. 

DLBCL develops when some of your B-cells become cancerous and are spread out (diffuse) rather than grouped closely together. They grow uncontrollably, are abnormal, and do not die when they should.  

Although DLBCL is usually a fast growing (aggressive) lymphoma, many people with DLBCL can be cured with treatment, even if you are diagnosed with an advanced stage. An advanced stage of lymphoma is very different to advanced stages of other cancers which cannot be cured.

Causes of Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While a diagnosis can feel overwhelming, understanding your lymphoma is an important first step. This section covers the biology behind DLBCL, what causes it, its subtypes, and what your genetics may mean for your diagnosis and treatment.

Heading 2

Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. While a diagnosis can feel overwhelming, understanding your lymphoma is an important first step. This section covers the biology behind DLBCL, what causes it, its subtypes, and what your genetics may mean for your diagnosis and treatment.

Heading 2

On This Page

This educational resource hub was proudly sponsored by

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.